Semafit vs Ozempic: Comparison Guide

Semafit vs Ozempic: A Practical Comparison

The conversation around health, diabetes management, and weight care is evolving, and with it comes a lot of new information and new names. You may have heard about semaglutide, the active ingredient in medications that have gained significant attention. In India, two names you might encounter are Ozempic and Semafit.

While both are forms of semaglutide, understanding their similarities and differences can help you have a more informed conversation with your doctor. This guide offers a clear, practical comparison to demystify these two medications. Consult your healthcare provider before starting any medication.

What is Semaglutide?

Before we compare the brands, let's understand the foundation: semaglutide itself. Semaglutide is a medication that belongs to a class of drugs called GLP-1 (glucagon-like peptide-1) receptor agonists.

In simple terms, it works by mimicking a natural hormone in your body. This hormone helps to:

• Regulate blood sugar levels, which is its primary function in managing type 2 diabetes.
• Slow down how quickly food leaves your stomach, leading to a feeling of fullness for longer.
• Signal to the brain that you are full, which can help reduce overall appetite.

Because of these effects, semaglutide has been approved for the management of type 2 diabetes and, in some formulations, for chronic weight management.

Introducing Ozempic

Brand and Manufacturer

Ozempic is the brand name for injectable semaglutide manufactured by Novo Nordisk, a global pharmaceutical company headquartered in Denmark. It has been available internationally for several years and is one of the most widely recognized brands of semaglutide.

Formulation and Administration

Ozempic is administered as a once-weekly injection using a pre-filled pen device. The injection is subcutaneous, meaning it goes into the fatty tissue just under the skin, typically in the abdomen, thigh, or upper arm.

Approved Use in India

In India, the Central Drugs Standard Control Organisation (CDSCO) has approved Ozempic for improving glycaemic control in adults with type 2 diabetes mellitus. Novo Nordisk launched it in India in December 2025.

Introducing Semafit

Brand and Manufacturer

Semafit is a brand name for semaglutide. Medical Dialogues (March 2026) listed it among the generic semaglutide brands lined up for launch in India by Ajanta Pharma, after Novo Nordisk's core Indian patent on semaglutide expired in March 2026. As of October 2026 we could not confirm Semafit's launch, strengths, device or approved uses from the company or the regulator, so check the pack and leaflet, and ask your doctor or pharmacist, before relying on any detail. Generic semaglutide brands in India differ in approved use (some are approved for type 2 diabetes only, others also for weight management) and in format (disposable pens, reusable cartridge pens or multi-dose vials).

Formulation and Administration

As a semaglutide product, Semafit would be a once-weekly subcutaneous injection, but whether it comes as a disposable pen, a cartridge pen or a vial should be checked on the pack.

Approved Use in India

Check the pack or leaflet for Semafit's approved use; generic semaglutide brands in India are approved for type 2 diabetes, and some also for weight management.

Key Similarities: What They Share

When you look past the packaging, Ozempic and Semafit have a great deal in common. Their core therapeutic function is identical.

The Active Ingredient

This is the most crucial similarity. Both Ozempic and Semafit contain the exact same active pharmaceutical ingredient: semaglutide. This means they are designed to work in the body in the same way.

Mechanism of Action

Because they share the same active ingredient, their mechanism of action is identical. Both are GLP-1 receptor agonists that help manage blood sugar and can influence appetite and feelings of fullness.

Method and Frequency

Both are once-weekly injections of semaglutide. The device may differ, so ask your pharmacist to show you how to use the one you are given, and do not switch brands or devices without your prescriber.

Potential Side Effects

As with any medication, semaglutide can have side effects. Since the active ingredient is the same, the potential side effect profile for both Ozempic and Semafit is similar. Common side effects can include nausea, vomiting, diarrhoea, abdominal pain, and constipation. These are often mild to moderate and may decrease over time as your body adjusts.

When to get urgent help: contact a doctor or emergency services straight away for severe stomach pain that does not go away, with or without vomiting and sometimes spreading to the back (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of the skin or eyes (possible gallbladder problems); vomiting or diarrhoea that stops you keeping fluids down (risk of dehydration and kidney injury); or swelling of the face or throat or trouble breathing (possible severe allergic reaction). Semaglutide should not be used by people with a personal or family history of medullary thyroid carcinoma or MEN 2. Tell your doctor if you are pregnant or planning a pregnancy, if you have diabetic eye disease, or if you have surgery or sedation planned. If you also take insulin or a sulfonylurea, your doctor may need to adjust those medicines to lower the risk of low blood sugar.

Key Differences: What Sets Them Apart

The differences between Ozempic and Semafit are not clinical but rather logistical and contextual.

Manufacturer and Origin

The most significant difference is the company behind each brand. Ozempic is made by the global innovator Novo Nordisk, while Semafit was listed as an Ajanta Pharma brand.

Availability

A domestically manufactured product can sometimes have different supply chain dynamics compared to an imported one. The availability of either option in your specific city or pharmacy may vary, and this is a practical factor your doctor and pharmacist can provide insight on.

The Pen Device

The device can differ. Some generic semaglutide brands in India come as disposable pens, some as reusable cartridge pens and some as multi-dose vials used with a syringe. Dose markings and steps differ between devices, so learn the one you are prescribed from your doctor or pharmacist.

Making an Informed Decision with Your Doctor

Choosing between Semafit and Ozempic is not a decision to make in isolation. It is a prescription medication that requires a thorough evaluation by a qualified healthcare professional.

Your doctor will consider your complete medical history, your specific health goals, and your overall treatment plan. They are your best resource for understanding which medication, if any, is appropriate for you. They can discuss the nuances of each option and help you navigate the path forward safely. Remember, the goal is to find the right fit for your unique health journey.

This guide is for informational purposes only and is not a substitute for professional medical advice. Consult your healthcare provider before starting any medication.

Sources

• https://cdsco.gov.in/opencms/opencms/en/Home/
• https://www.novonordisk.co.in/
• https://medicaldialogues.in/news/industry/pharma/indias-semaglutide-market-set-for-generic-boom-as-patents-expire-over-50-brands-lined-up-for-launch-see-full-list-165838
• Biopharma APAC: Semaglutide generics, six months in: every launch in India (October 2026): https://biopharmaapac.com/analysis/23/8540/semaglutide-generics-six-months-in-every-launch-in-india-every-price-and-where-china-stands.html
• https://www.niddk.nih.gov/health-information/weight-management/prescription-medications-treat-overweight-obesity
• https://www.ozempic.com/